Max N. Dawson

Biography

  Max N. Dawson is the Vice President of business development and head of licensing at Adagene. He has extensive experience in partnering and strategic planning, and is focused on fostering synergistic relationship in the pharmaceutical and biotech industry for the purpose of advancing human healthcare. Prior to joining Adagene, Max consulted for private and venture backed technology companies in the US and Asia, advising on corporate strategy and licensing at the executive and board level. He also spent several years running the licensing division at Dyax Corp., where he participated in over 30 transactions and debt financings. Prior to this, Max has held finance positions at both Vertex Pharmaceuticals and Merck KGaA. Before his roles in finance and business development, Max was a bench scientist in the protein biochemistry department at Vertex Pharmaceuticals. Max holds an M.B.A from the F.W. Olin Graduate School of Business at Babson College, where he has guest lectured on marketing and biotechnology. He completed his undergraduate work at Bates College.

Research Interest

  pharmaceutical and biotech industry